Improved identification of patients 'at risk' of depression, and optimal targeting of rehabilitation post-stroke through novel brain imaging and biomarkers.

使用新的脑成像和生物标志物来识别有抑郁和复发性卒中风险的卒中幸存者，将允许抢先体验获得预防性和有效的抑郁治疗，并提高从康复中获益的能力。开发预测模型以指导基于可行大脑的最佳康复策略的选择，将最大限度地提高中风患者充分发挥康复潜力的能力，并确保康复更具针对性和成本效益。改善从治疗中获益的能力将对经历中风的澳大利亚人的活动参与和生产性生活产生持续的益处。

Use of novel brain imaging and biomarkers for identification of stroke survivors at risk of depression and recurrent stroke will permit early access to preventative and effective treatments for depression and improve capacity to benefit from rehabilitation. Development of predictive models to guide selection of most optimal rehabilitation strategies based on viable brain will maximise the capacity for persons with stroke to reach their full potential for recovery and ensure rehabilitation is more targeted and cost efficient. Improved capacity to benefit from treatment will have ongoing benefits for activity participation and productive living in Australians who experience stroke.